Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-22-013676
Filing Date
2022-05-16
Accepted
2022-05-16 14:39:05
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 559316
2 ex10-1.htm EX-10.1 48859
3 ex31-1.htm EX-31.1 18968
4 ex31-2.htm EX-31.2 18399
5 ex32-1.htm EX-32.1 6783
6 ex32-2.htm EX-32.2 6330
  Complete submission text file 0001493152-22-013676.txt   3025672

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rgts-20220331.xsd EX-101.SCH 23475
8 XBRL CALCULATION FILE rgts-20220331_cal.xml EX-101.CAL 27211
9 XBRL DEFINITION FILE rgts-20220331_def.xml EX-101.DEF 116979
10 XBRL LABEL FILE rgts-20220331_lab.xml EX-101.LAB 219598
11 XBRL PRESENTATION FILE rgts-20220331_pre.xml EX-101.PRE 188924
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 332688
Mailing Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954
Business Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954 415-578-9583
RetinalGenix Technologies Inc. (Filer) CIK: 0001836295 (see all company filings)

EIN.: 823936890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-258528 | Film No.: 22927830
SIC: 3841 Surgical & Medical Instruments & Apparatus